CME Group Inc. (NASDAQ:CME) Shares Sold by Seeyond

Seeyond trimmed its stake in shares of CME Group Inc. (NASDAQ:CME) by 0.5% during the 2nd quarter, Holdings Channel reports. The fund owned 9,226 shares of the financial services provider’s stock after selling 49 shares during the quarter. Seeyond’s holdings in CME Group were worth $1,962,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently bought and sold shares of the stock. Ossiam grew its holdings in CME Group by 1,369.2% during the second quarter. Ossiam now owns 9,814 shares of the financial services provider’s stock worth $2,082,000 after acquiring an additional 9,146 shares during the period. Toroso Investments LLC boosted its position in CME Group by 73.9% during the second quarter. Toroso Investments LLC now owns 109,704 shares of the financial services provider’s stock worth $23,332,000 after purchasing an additional 46,626 shares in the last quarter. Kore Private Wealth LLC boosted its position in CME Group by 24.9% during the second quarter. Kore Private Wealth LLC now owns 1,492 shares of the financial services provider’s stock worth $317,000 after purchasing an additional 297 shares in the last quarter. Inscription Capital LLC purchased a new position in CME Group during the second quarter worth approximately $675,000. Finally, PAX Financial Group LLC boosted its position in CME Group by 4.9% during the second quarter. PAX Financial Group LLC now owns 3,134 shares of the financial services provider’s stock worth $667,000 after purchasing an additional 146 shares in the last quarter. 86.19% of the stock is currently owned by hedge funds and other institutional investors.

CME has been the topic of a number of recent analyst reports. TheStreet downgraded CME Group from a “b” rating to a “c+” rating in a research report on Wednesday, August 18th. Piper Sandler restated a “buy” rating and issued a $230.00 target price on shares of CME Group in a research report on Friday, October 1st. Atlantic Securities upgraded CME Group from a “neutral” rating to an “overweight” rating and set a $230.00 target price on the stock in a research report on Tuesday, September 14th. Berenberg Bank restated a “hold” rating on shares of CME Group in a research report on Wednesday, September 15th. Finally, Morgan Stanley decreased their target price on CME Group from $229.00 to $217.00 and set an “equal weight” rating on the stock in a research report on Friday, October 8th. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $211.38.

In other news, insider Sean Tully sold 5,000 shares of CME Group stock in a transaction on Tuesday, August 24th. The stock was sold at an average price of $200.20, for a total value of $1,001,000.00. Following the completion of the sale, the insider now directly owns 23,479 shares of the company’s stock, valued at $4,700,495.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Martin J. Gepsman sold 1,000 shares of CME Group stock in a transaction on Monday, September 13th. The shares were sold at an average price of $188.53, for a total value of $188,530.00. Following the completion of the sale, the director now directly owns 24,468 shares of the company’s stock, valued at $4,612,952.04. The disclosure for this sale can be found here. In the last three months, insiders have sold 9,000 shares of company stock valued at $1,786,150. 0.30% of the stock is owned by insiders.

CME stock traded up $1.35 during midday trading on Thursday, hitting $205.61. 11,155 shares of the company’s stock were exchanged, compared to its average volume of 1,438,494. The business has a 50-day simple moving average of $198.24 and a two-hundred day simple moving average of $206.47. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The stock has a market capitalization of $73.84 billion, a PE ratio of 38.18 and a beta of 0.43. CME Group Inc. has a 1-year low of $146.89 and a 1-year high of $221.82.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, July 28th. The financial services provider reported $1.64 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.59 by $0.05. The company had revenue of $1.18 billion during the quarter, compared to analysts’ expectations of $1.17 billion. CME Group had a return on equity of 8.33% and a net margin of 41.64%. As a group, research analysts expect that CME Group Inc. will post 6.65 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Monday, September 27th. Shareholders of record on Friday, September 10th were paid a dividend of $0.90 per share. The ex-dividend date was Thursday, September 9th. This represents a $3.60 annualized dividend and a yield of 1.75%. CME Group’s dividend payout ratio (DPR) is 53.57%.

CME Group Profile

CME Group, Inc operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals.

Read More: How to start trading in the forex market?

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.